FDA Commish Says Sarepta's DMD Study Should Be Retracted
September 22, 2016 at 10:24 AM EDT
It looks like Sarepta Therapeutics Inc (NASDAQ: SRPT)'sEteplirsen may not be out of the woods just yet. A letter ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.